RXRX — Recursion Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Recursion Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	262	517	550	392	594
Net Total Accounts Receivable
Net Total Receivables	0.156	9.09	2.75	3.09	49.2
Total Other Current Assets
Total Current Assets	266	535	570	438	714
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	26	64.7	121	120	233
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	299	610	701	654	1,449
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23.1	46.7	100	93.2	187
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	56.6	67.4	215	190	414
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	242	543	486	463	1,035
Total Liabilities & Shareholders' Equity	299	610	701	654	1,449
Total Common Shares Outstanding